Immuneering Corporation

Immuneering Corporation financial statements

Immuneering Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 56.02M10-K
Cash and equivalentsUSD 128.65M10-Q

Immuneering Corporation financials on 6ix · Immuneering Corporation on 6ix